These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23764641)

  • 21. A top scoring pairs classifier for recent HIV infections.
    Chen A; Laeyendecker O; Eshleman SH; Monaco DR; Kammers K; Larman HB; Ruczinski I
    Stat Med; 2021 May; 40(11):2604-2612. PubMed ID: 33660319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical power and estimation of incidence rate ratios obtained from BED incidence testing for evaluating HIV interventions among young people.
    Auvert B; Mahiane GS; Lissouba P; Moreau T
    PLoS One; 2011; 6(8):e21149. PubMed ID: 21853019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
    Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
    Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
    Laeyendecker O; Piwowar-Manning E; Fiamma A; Kulich M; Donnell D; Bassuk D; Mullis CE; Chin C; Swanson P; Hackett J; Clarke W; Marzinke M; Szekeres G; Gray G; Richter L; Alexandre MW; Chariyalertsak S; Chingono A; Celentano DD; Morin SF; Sweat M; Coates T; Eshleman SH
    PLoS One; 2013; 8(7):e68349. PubMed ID: 23874597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data.
    Rajan SS; Sokal D
    J Epidemiol Community Health; 2011 Feb; 65(2):111-5. PubMed ID: 20558420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.
    Chu H; Cole SR
    Biom J; 2006 Aug; 48(5):772-9. PubMed ID: 17094342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling methods for estimating HIV incidence: a mathematical review.
    Sun X; Nishiura H; Xiao Y
    Theor Biol Med Model; 2020 Jan; 17(1):1. PubMed ID: 31964392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional HIV incidence estimation in an evolving epidemic.
    Morrison D; Laeyendecker O; Brookmeyer R
    Stat Med; 2019 Aug; 38(19):3614-3627. PubMed ID: 31115081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.
    Novitsky V; Wang R; Kebaabetswe L; Greenwald J; Rossenkhan R; Moyo S; Musonda R; Woldegabriel E; Lagakos S; Essex M
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):265-72. PubMed ID: 19525854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
    McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of HIV-1 Incidence Using a Testing History-Based Method; Analysis From the Population-Based HIV Impact Assessment Survey Data in 12 African Countries.
    Gurley SA; Stupp PW; Fellows IE; Parekh BS; Young PW; Shiraishi RW; Sullivan PS; Voetsch AC
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):189-196. PubMed ID: 36730779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi.
    Taha TE; Dallabetta GA; Hoover DR; Chiphangwi JD; Mtimavalye LA; Liomba GN; Kumwenda NI; Miotti PG
    AIDS; 1998 Jan; 12(2):197-203. PubMed ID: 9468369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
    Facente SN; Grebe E; Maher AD; Fox D; Scheer S; Mahy M; Dalal S; Lowrance D; Marsh K
    JMIR Public Health Surveill; 2022 Mar; 8(3):e34410. PubMed ID: 35275085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China.
    Hammett TM; Des Jarlais DC; Kling R; Kieu BT; McNicholl JM; Wasinrapee P; McDougal JS; Liu W; Chen Y; Meng D; Doan N; Tho HN; Quyen NH; Tren VH
    PLoS One; 2012; 7(8):e43141. PubMed ID: 22952640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data.
    Cole SR; Chu H; Brookmeyer R
    Am J Epidemiol; 2007 Jan; 165(1):94-100. PubMed ID: 17056640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How should we best estimate the mean recency duration for the BED method?
    Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
    PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengthening HIV surveillance: measurements to track the epidemic in real time.
    Buthelezi UE; Davidson CL; Kharsany AB
    Afr J AIDS Res; 2016 Jul; 15(2):89-98. PubMed ID: 27399039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size methods for estimating HIV incidence from cross-sectional surveys.
    Konikoff J; Brookmeyer R
    Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.